The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as they received a short-term exemption this week under President Donald Trump’s sweeping new ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

But the markets remain spooked by US President Donald Trump’s warning that pharma tariffs shall be imposed at “levels you ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

David Anchell, founder and managing director of Camida, said the ongoing uncertainty for pharma would make Ireland ‘less ...

Indian pharmaceutical stocks experienced a significant drop on Friday, with the Nifty Pharma Index falling 4.4%, erasing the ...

But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in February to impose “25% or higher” levies on imported drugs.

The deal includes the purchase of product dossiers, marketing authorisations, intellectual property, and inventory ...

"themeId": "lct_653b7fa7fed115003648bab8", "clientId": "64772ae4d1d7dec0c5b716af", "liveblogId": "67ea5efb9b66b38dded9cb29"} ...